MDT

98.64

+1.99%↑

135.65

-2.83%↓

VEEV

215.94

-2.8%↓

HQY

83.67

-1.59%↓

NEOG

9.34

+1.19%↑

MDT

98.64

+1.99%↑

135.65

-2.83%↓

VEEV

215.94

-2.8%↓

HQY

83.67

-1.59%↓

NEOG

9.34

+1.19%↑

MDT

98.64

+1.99%↑

135.65

-2.83%↓

VEEV

215.94

-2.8%↓

HQY

83.67

-1.59%↓

NEOG

9.34

+1.19%↑

MDT

98.64

+1.99%↑

135.65

-2.83%↓

VEEV

215.94

-2.8%↓

HQY

83.67

-1.59%↓

NEOG

9.34

+1.19%↑

MDT

98.64

+1.99%↑

135.65

-2.83%↓

VEEV

215.94

-2.8%↓

HQY

83.67

-1.59%↓

NEOG

9.34

+1.19%↑

Начало・Списък с акции・Schrodinger Inc

Schrodinger Inc

Затворен

СекторЗдравеопазване

16.31 -2.34

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

16.21

Максимум

16.7

Ключови измерители
By Trading Economics
Приходи	10M -33M
Продажби	-435K 54M
Марж на печалбата	-60.369
Служители	891
EBITDA	10M -31M

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+30.02% upside

Дивиденти
By Dow Jones
Следващи печалби	25.02.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-139M 1.4B
Предишно отваряне	18.65
Предишно затваряне	16.31

Настроения в новините

By Acuity

63%

37%

323 / 361 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Very Strong Bearish Evidence

23.27 / 26.13 Подкрепа & съпротива

Schrodinger Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

19.01.2026 г., 16:17 ч. UTC

Придобивния, сливания и поглъщания

Zurich Insurance Makes $10 Billion Bid for U.K. Specialist Insurer Beazley -- Update

19.01.2026 г., 23:50 ч. UTC

Пазарно говорене

Nikkei May Decline Amid Uncertainty Over U.S.-Europe Relations -- Market Talk

19.01.2026 г., 23:42 ч. UTC

Пазарно говорене

Gold Edges Lower on Likely Technical Correction -- Market Talk

19.01.2026 г., 22:29 ч. UTC

Пазарно говорене

China Infant Formula Market May Hold Up Despite Steep Drop in Births -- Market Talk

19.01.2026 г., 22:29 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

19.01.2026 г., 21:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

19.01.2026 г., 21:50 ч. UTC

Пазарно говорене

Health Care Roundup: Market Talk

19.01.2026 г., 21:15 ч. UTC

Пазарно говорене

Global Commodities Roundup: Market Talk

19.01.2026 г., 17:20 ч. UTC

Пазарно говорене

Health Care Roundup: Market Talk

19.01.2026 г., 17:20 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

19.01.2026 г., 17:15 ч. UTC

Пазарно говорене

Global Commodities Roundup: Market Talk

19.01.2026 г., 17:09 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

19.01.2026 г., 17:09 ч. UTC

Пазарно говорене

Copper Rises in Spite of Softer Dollar, Trade Concerns -- Market Talk

19.01.2026 г., 16:18 ч. UTC

Пазарно говорене

New Zealand Dollar Could Recover Against Swedish Krona -- Market Talk

19.01.2026 г., 16:12 ч. UTC

Пазарно говорене

Norwegian Krone's Recent Gains Are Unlikely to Last -- Market Talk

19.01.2026 г., 16:06 ч. UTC

Придобивния, сливания и поглъщания

LVMH: Deal Completion Subject to Customary Closing Conditions and Expected to Close in Around Two Months

19.01.2026 г., 16:04 ч. UTC

Придобивния, сливания и поглъщания

LVMH: Both Parties Aim to Set Up Strategic Cooperation in the Retail Sector

19.01.2026 г., 16:03 ч. UTC

Придобивния, сливания и поглъщания

LVMH, CTG Duty-Free Also Entered Into a MoU

19.01.2026 г., 16:02 ч. UTC

Придобивния, сливания и поглъщания

LVMH: Subscription to Be Made Upon Completion of Transaction

19.01.2026 г., 16:00 ч. UTC

Придобивния, сливания и поглъщания

LVMH: Capital Increase by Subscribing to Newly Issued H-shares Listed in Hong Kong

19.01.2026 г., 16:00 ч. UTC

Пазарно говорене

Term Premium on U.S. Treasurys Looks Too Low, Says Pictet AM -- Market Talk

19.01.2026 г., 15:58 ч. UTC

Придобивния, сливания и поглъщания

LVMH and the Miller Family Will Participate in a Capital Increase of CTG DutyFree

19.01.2026 г., 15:57 ч. UTC

Придобивния, сливания и поглъщания

LVMH: DFS Will Continue to Operate Its Other Luxury Travel Retail Operations Worldwide

19.01.2026 г., 15:57 ч. UTC

Придобивния, сливания и поглъщания

LVMH: Proceeds of Transaction Will Be Paid in Cash

19.01.2026 г., 15:56 ч. UTC

Придобивния, сливания и поглъщания

LVMH: CTG Duty-Free Will Run the Acquisition Through Its Subsidiary China Duty Free International Limited

19.01.2026 г., 15:53 ч. UTC

Придобивния, сливания и поглъщания

LVMH: Intangible Assets Include a Series of DFS Brands and IP for Exclusive Use in Greater China

19.01.2026 г., 15:52 ч. UTC

Придобивния, сливания и поглъщания

LVMH: CTG Duty-Free to Acquire the DFS Retail Stores in Hong Kong and Macau and Intangible Assets

19.01.2026 г., 15:51 ч. UTC

Придобивния, сливания и поглъщания

LVMH: DFS, CTG Duty-Free Reach Definitive Pact for CTG Duty-Free to Buy DFS' Travel Retail Unit in Hong Kong and Macau and Intangible Assets in Greater China

19.01.2026 г., 15:39 ч. UTC

Пазарно говорене

Canadian Dollar's Underperformance Looks Overstretched -- Market Talk

19.01.2026 г., 15:37 ч. UTC

Пазарно говорене

Bank of Canada Could Consider Cutting Rates if Underlying Inflation Slows Further -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Schrodinger Inc Прогноза

Ценова цел

By TipRanks

30.02% нагоре

12-месечна прогноза

Среден 21.83 USD 30.02%

Висок 25 USD

Нисък 18 USD

Според 7 анализатори от Wall Street, предложили 12-месечна ценова цел за Schrodinger Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

7 ratings

Купи

Задържане

Продай

Според 7 анализатори, дали борсови рейтинги на Schrodinger Inc през последните 3 месеца.

Техническа оценка

By Trading Central

23.27 / 26.13Подкрепа & съпротива

Recent bearish events outweigh bullish events.

All events are bullish.

Настроение

By Acuity

323 / 361 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Schrodinger Inc

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. It has a research collaboration and license agreement with Novartis AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.